CycleZyme Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Public

  • Employees
  • 7

Employees

  • Stock Symbol
  • CYCLE

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $1.82
  • (As of Friday Closing)

CycleZyme General Information

Description

Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Scheelevägen 22
  • 223 63 Lund
  • Sweden
+46
Primary Industry
Specialty Chemicals
Other Industries
Environmental Services (B2B)
Stock Exchange
SAT
Vertical(s)
Corporate Office
  • Scheelevägen 22
  • 223 63 Lund
  • Sweden
+46

CycleZyme Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CycleZyme Stock Performance

As of 20-Nov-2026, CycleZyme’s stock price is $1.82. Its current market cap is $5.13M with 2.82M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.82 $1.77 $1.09 - $5.03 $5.13M 2.82M 7.21K -$0.09

CycleZyme Financials Summary

As of 30-Jun-2026, CycleZyme has a trailing 12-month revenue of $236K.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 5,974 4,006 1,178
Revenue 236 86 0 0
EBITDA (217) (152) (199) (142)
Net Income (226) (161) (202) (143)
Total Assets 737 938 526 815
Total Debt 28 36 44 50
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CycleZyme Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CycleZyme‘s full profile, request access.

Request a free trial

CycleZyme Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore CycleZyme‘s full profile, request access.

Request a free trial

CycleZyme Patents

CycleZyme Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4534591-A2 Process for depolymerizing polyester substrates using microwave-assisted enzymatic action Active 14-Jul-2023
EP-4534591-A3 Process for depolymerizing polyester substrates using microwave-assisted enzymatic action Active 14-Jul-2023
EP-4534591-B1 Process for depolymerizing polyester substrates using microwave-assisted enzymatic action Active 14-Jul-2023
EP-4534591-C0 Process for depolymerizing polyester substrates using microwave-assisted enzymatic action Active 14-Jul-2023
WO-2025016894-A2 Process for depolymerizing polyester substrates using microwave-assisted enzymatic action Inactive 14-Jul-2023 C08J11/105
To view CycleZyme’s complete patent history, request access »

CycleZyme Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CycleZyme Investments (1)

CycleZyme’s most recent deal was a Corporate Asset Purchase with Ragn-Sells (Melanin Process IP in Sollentuna, Sweden). The deal was made on 10-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ragn-Sells (Melanin Process IP in Sollentuna, Sweden) 10-Sep-2026 Corporate Asset Purchase Buildings and Property
To view CycleZyme’s complete investments history, request access »

CycleZyme ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Chemicals

Industry

Rank

Percentile

Commodity Chemicals

Subindustry

Rank

Percentile

To view CycleZyme’s complete esg history, request access »

CycleZyme FAQs

  • When was CycleZyme founded?

    CycleZyme was founded in 2020.

  • Where is CycleZyme headquartered?

    CycleZyme is headquartered in Lund, Sweden.

  • What is the size of CycleZyme?

    CycleZyme has 7 total employees.

  • What industry is CycleZyme in?

    CycleZyme’s primary industry is Specialty Chemicals.

  • Is CycleZyme a private or public company?

    CycleZyme is a Public company.

  • What is CycleZyme’s stock symbol?

    The ticker symbol for CycleZyme is CYCLE.

  • What is the current stock price of CycleZyme?

    As of 20-Nov-2026 the stock price of CycleZyme is $1.82.

  • What is the current market cap of CycleZyme?

    The current market capitalization of CycleZyme is $5.13M.

  • What is CycleZyme’s current revenue?

    The trailing twelve month revenue for CycleZyme is $236K.

  • What is CycleZyme’s annual earnings per share (EPS)?

    CycleZyme’s EPS for 12 months was -$0.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process